E83.111 vs T80.82XD
E83.111 (Hemochromatosis due to repeated red blood cell transfusions) compared with T80.82XD (Complication of immune effector cellular therapy, subsequent encounter), from the official CMS tabular data. Both may be reported when both conditions are documented (Excludes2).
Can these codes be reported together?
Yes, when both are documented. T80.82XD carries an Excludes2 note covering E83.111: “transfusion (red blood cell) associated hemochromatosis (E83.111)”
Excludes2 marks distinct conditions — both may be reported when both are documented.
Side by side
| E83.111Hemochromatosis due to repeated red blood cell transfusions | T80.82XDComplication of immune effector cellular therapy, subsequent encounter | |
|---|---|---|
| Billing status | Billable | Billable |
| Classification | E00-E89 — Endocrine, Nutritional and Metabolic Diseases (E00-E89) | S00-T88 — Injury, Poisoning and Certain Other Consequences of External Causes (S00-T88) |
| Definition | Hemochromatosis due to repeated red blood cell transfusions is a billable ICD-10-CM diagnosis code (E83.111). | Complication of immune effector cellular therapy, subsequent encounter is a billable ICD-10-CM diagnosis code (T80.82D). |
| 7th character | — | The appropriate 7th character is to be added to each code from category T80 |
| Includes | Iron overload due to repeated red blood cell transfusions Transfusion (red blood cell) associated hemochromatosis | complications following perfusion Complication of chimeric antigen receptor (CAR-T) cell therapy Complication of IEC therapy |
| Use additional code | — | code to identify the specific complication, such as: cytokine release syndrome (D89.83-) immune effector cell-associated neurotoxicity syndrome (G92.0-) |
Derived from the official CMS ICD-10-CM tabular data (FY2026). Not billing advice; verify sequencing rules for the encounter. All data sources